A 2025 review in The Journal of Clinical Endocrinology & Metabolism explains that GLP-1 receptor agonists slow gastric emptying and small-intestinal motility, which is part of how they affect blood sugar and post-meal metabolism
The Tirzepatide program at Hawaii Wellness Clinic is particularly well suited for patients who have a BMI of 30 or greater, or 27 or greater with weight-related health conditions, have tried semaglutide or other GLP-1 medications without achieving adequate results, have significant insulin resistance, metabolic syndrome, or type 2 diabetes requiring stronger metabolic intervention, need more powerful appetite suppression to manage persistent hunger and cravings, are seeking the most aggressive non-surgical, medically supervised weight loss results currently available, or want to address substantial cardiovascular risk factors such as elevated triglycerides, low HDL, and elevated blood sugar alongside weight loss
SF was collected from knee joints during TKA for end-stage primary KOA ( n = 2 men, 8 women) or end-stage seropositive RA ( n = 3 men, 7 women)
Before starting, a doctor must screen for contraindications, medical conditions that make these drugs unsafe